Q-linea: Robust commercial evaluation feedback - Redeye

Q-linea's announcement regarding the commercial validation study together with the launch partner Therma Fisher is good news and well-timed as Thermo Fisher Scientific is in the process of launching ASTar in Europe. Our value proposition is a base of SEK 180 (Bull SEK 230 and Bear SEK 90).

Länk till analysen i sin helhet: https://www.redeye.se/research/833125/q-linea-robust-commercial-evaluation-feedback?utm_source=finwire&utm_medium=RSS